Design and development of controlled release floating matrix tablet of Nicorandil using hydrophilic cellulose and pH-independent acrylic polymer: in-vitro and in-vivo evaluations

References

• Kumar V. Target-oriented drug delivery systems. In: Florence AT, Siepmann J, editors. Modern pharmaceutics. USA: Informa Healthcare; 2009.
   Google Scholar
• Khosla R, Davis SS. Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int J Pharm. 1989;52:1–10. doi:10.1016/0378-5173(89)90082-3.
   Web of Science ®Google Scholar
• Gupta PK, Robinson JR. Oral controlled-release delivery. In: Kydonieus A, editor. Treatise on controlled drug delivery. New York, NY: Marcel Dekker; 1992.
   Google Scholar
• Wang J, Tabata Y, Bi D, et al. Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres. J Control Release. 2001;73:223–231.
   PubMed Web of Science ®Google Scholar
• Tamburic S, Craig DQM. The effects of aging on the rheological, dielectric and mucoadhesive properties of poly (acrylic acid) gel systems. Pharm Res. 1996;13:279–283. doi:10.1023/A:1016003400886.
   PubMed Web of Science ®Google Scholar
• Kapil R, Dhawan S, Singh B, et al. Systematic formulation development of once-a-day gastroretentive controlled release tablets of rivastigmine using optimized polymer blends. J Drug Deliv Sci Tec. 2012;22(6):511–521. doi:10.1016/S1773-2247(12)50090-0.
   Web of Science ®Google Scholar
• Peppas NA, Little MD, Huang Y, et al. Bioadhesive controlled release systems. In: Wise DL, editor. Handbook of pharmaceutical controlled release technology. New York, NY: Marcel Dekker; 2000.
   Google Scholar
• Singh B, Garg B, Chaturvedi S, et al. Formulation development of gastroretentive tablets of lamivudine using the floating-bioadhesive potential of optimized polymer blends. J Pharm Pharmacol. 2012;64(5):654–669. doi:10.1111/j.2042-7158.2011.01442.x.
   PubMed Web of Science ®Google Scholar
• Li S, Lin S, Daggy BP, et al. Effect of HPMC and Carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int J Pharm. 2003;253:13–22. doi:10.1016/S0378-5173(02)00642-7.
   PubMed Web of Science ®Google Scholar
• Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int J Pharm. 1992;86:79–88. doi:10.1016/0378-5173(92)90033-X.
   Web of Science ®Google Scholar
• Singh B, Rani A, Ahuja N, et al. Formulation optimization of hydrodynamically balanced oral controlled bioadhesive tablets of tramadole hydrochloride. Scientia Pharmaceutica. 2010;78(2):303–323. doi:10.3797/scipharm.1001-04.
   PubMedGoogle Scholar
• Fix JA, Cargill R, Engle K. Controlled gastric emptying: Part 3. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm Res. 1993;10:1087–1089. doi:10.1023/A:1018939512213.
   PubMed Web of Science ®Google Scholar
• Chen J, Blevins WE, Park H, et al. Gastric retention properties of superporous hydrogel composites. J Control Release. 2000;64:39–51. doi:10.1016/S0168-3659(99)00139-X.
   PubMed Web of Science ®Google Scholar
• Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235–259. doi:10.1016/S0168-3659(99)00204-7.
   PubMed Web of Science ®Google Scholar
• Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res. 2008;7(3):1055–1066. doi:10.4314/tjpr.v7i3.14691.
   Web of Science ®Google Scholar
• Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm. 2008;69(3):1019–1028. doi:10.1016/j.ejpb.2008.01.011.
   PubMed Web of Science ®Google Scholar
• Leonetti G, Fruscio M, Gradnik R, et al. Nicorandil, a new vasodilator drug, in patients with essential hypertension. J Hypertens. 1989;7:S292–S293. doi:10.1097/00004872-198900076-00142.
   Google Scholar
• Camm AJ, Maltz MB. A controlled single-dose study of the efficacy, dose response and duration of action of Nicorandil in angina pectoris. Am J Cardiol. 1989;20(21):61J–65J. doi:10.1016/0002-9149(89)90207-5.
   Google Scholar
• Sweetman SC. Martindale: the complete drug reference. 34th ed. London: The Pharmaceutical Press; 2005. ( Electronic version).
   Google Scholar
• Jin Y, Ohkuma H, Wang H, et al. Fast-disintegration oral tablets having sustained release property. Yakugaku Zasshi. 2002;122(11):989–994. doi:10.1248/yakushi.122.989.
   PubMed Web of Science ®Google Scholar
• Frydman A. Pharmacokinetic profile of nicorandil in humans: an overview. J Cardiovasc Pharmacol. 1992;20:S34–44. doi:10.1097/00005344-199206203-00008.
   PubMed Web of Science ®Google Scholar
• Dollery C. Therapeutic drugs. New York, NY: Churchill Livingstone; 1999.
   Google Scholar
• Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics a treatise. Delhi, India: Vallabh Prakashan; 2013.
   Google Scholar
• Rowland M, Tozer TN. Clinical pharmacokinetics and pharmacodynamics: concept and applications. New York, NY: Lippincott Williams and Wilkins; 2011.
   Google Scholar
• Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech. 2003;4. article no. 61. doi:10.1208/pt040456.
   PubMedGoogle Scholar
• Xu X, Sun M, Zhi F, et al. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int J Pharm. 2006;310:139–145. doi:10.1016/j.ijpharm.2005.12.003.
   PubMed Web of Science ®Google Scholar
• Emami J, Tajeddin M, Ahmadi F. Preparation and in vitro evaluation of sustained-release matrix tablets of flutamide using synthetic and naturally occurring polymers. Iran J Pharm Res. 2008;7(4):247–257.
   Web of Science ®Google Scholar
• Gambhire MN, Ambade KW, Kurmi SD, et al. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride. AAPS PharmSciTech. 2007;8(3):E166-E174. Article 73 http://www.aapspharmscitech.org
   Google Scholar
• Jimenezcastellanos M, Zia H, Rhodes C, et al. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 1994;105:65–70. doi:10.1016/0378-5173(94)90236-4.
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35. doi:10.1016/0378-5173(83)90064-9.
   Web of Science ®Google Scholar
• Ahmed AB. Development and optimization of mucoadhesive matrix tablet for nicorandil: in-vitro evaluation and in-vivo gastro-retention. Inventi Impact: Pharm Tech. 2013;3:1–11.
   Google Scholar
• Ojha A, Pargal A. Determination of nicorandil concentrations in human plasma using liquid chromatography. J Pharm Biol Anal. 1999;21:175–178. doi:10.1016/S0731-7085(99)00102-8.
   PubMed Web of Science ®Google Scholar
• Kandarapu R, Grover V, Chawla HPS, et al. Evaluation of compatibility of ketorolac tromethamine with selected polymers and common tablet excipients by thermal and isothermal stress testing. STP Pharma Sci. 2001;11:449–457.
   Google Scholar
• Mura P, Manderioli A, Bramanti G, et al Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients. Int J Pharm. 1995;119:71–79. doi:10.1016/0378-5173(94)00374-E.
   Web of Science ®Google Scholar
• Botha SA, Lotter AP. Compatibility study between naproxen and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm. 1990;16:673–683. doi:10.3109/03639049009104410.
   Web of Science ®Google Scholar
• Smith A. Use of thermal analysis in predicting drug-excipient interactions. Anal Proc. 1982;19:559–561.
   Google Scholar
• Durig T, Fassihi AR. Identification of stabilizing and destabilizing effects of excipient–drug interactions in solid dosage form design. Int J Pharm. 1993;97:161–170. doi:10.1016/0378-5173(93)90136-4.
   Web of Science ®Google Scholar
• Malan CEP, de Villiers MM, Lotter AP, et al. Application of differential scanning calorimetry and high performance liquid chromatography to determine the effects of mixture composition and preparation during the evaluation of niclosamide-excipient compatibility. J Pharm Biomed Anal. 1997;15:549–557. doi:10.1016/S0731-7085(96)01869-9.
   PubMed Web of Science ®Google Scholar
• Venkataram S, Khohlokwane M, Wallis SH, et al. Differential scanning calorimetry as a quick scanning technique for solid state stability studies. Drug Dev Ind Pharm. 1995;21:847–855. doi:10.3109/03639049509026649.
   Web of Science ®Google Scholar
• Wan LS, Heng PW, Wong LF, et al. Matrix swelling: a simple model describing extent of swelling of HPMC matrices. Int J Pharm. 1995;116:159–168. doi:10.1016/0378-5173(94)00285-D.
   Web of Science ®Google Scholar
• Cohen JL, Hubert BB, Rhodes CT, et al. The development of USP dissolution and drug release standards. Pharm Res. 1990;7:983–987.
   PubMed Web of Science ®Google Scholar